Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
4.600
+0.050 (1.10%)
Oct 8, 2025, 10:28 AM EDT - Market open
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $49.68 million as of October 8, 2025. Its market cap has increased by 15.66% in one year.
Market Cap
49.68M
Enterprise Value
33.38M
1-Year Change
15.66%
Ranking
Category
Stock Price
$4.60
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $49.68M, an increase of 63.79%. That is a compound annual growth rate of 9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 49.14M | 42.83% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.24B |
| Johnson & Johnson | 452.08B |
| AbbVie | 411.34B |
| UnitedHealth Group | 328.79B |
| AstraZeneca | 265.89B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.88B |